Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: a case-control study

Publication date: Available online 7 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): William L. Conte

Source: Multiple Sclerosis and Related Disorders - May 7, 2021 Category: Neurology Source Type: research